Processa Pharmaceuticals, Inc. (PCSA): Total Assets
$7.81M
As of 2025-12-31
$2.07M
As of 2026-06-30
-3.2%
3-year compound annual growth
-20.9%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.81M | +142.0% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $3.23M | -44.2% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $5.79M | -32.9% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $8.62M | -67.4% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $26.46M | +5.0% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $25.21M | +131.7% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $10.88M | -12.8% | 2021-03-25, Balance as of period end |
| 2018-12-31 | $12.48M | +318.4% | 2020-03-06, Balance as of period end |
| 2017-12-31 | $2.98M | +26.1% | 2019-04-08, Balance as of period end |
| 2016-12-31 | $2.36M | n/m | 2018-04-16, Balance as of period end |
| 2015-12-31 | $104.3K | -95.9% | 2017-09-25, Balance as of period end |
| 2014-12-31 | $2.55M | -13.3% | 2017-06-19, Balance as of period end |
| 2013-12-31 | $2.94M | -24.4% | 2015-04-14, Balance as of period end |
| 2012-12-31 | $3.88M | n/a | 2014-03-27, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | $7.81M | +142.0% |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | $7.86M | +122.5% |
| Acurx Pharmaceuticals, Inc. (ACXP) | 2025-12-31 | $7.69M | +99.3% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $7.60M | -1.4% |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | $7.58M | -43.5% |
| GT Biopharma, Inc. (GTBP) | 2025-12-31 | $8.11M | n/a |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $7.45M | +33.1% |
| Revium Rx. (RVRC) | 2025-12-31 | $8.30M | -59.1% |
Compare PCSA, DRMA, ACXP, SILO side by side · Screen every company in Pharmaceutical Preparations ↗